PUBLICATIONS & ABSTRACTS


FIND MORE ANSWERS
ON MY BLOG

Publications:

  1. Rosenwaks Z and Licciardi F: In Vitro Fertilization: Patient Selection. Assisted Reproductive Techniques 1, 59, 1991. 
  2. Licciardi F, Grifo J, Rosenwaks Z, Witkins S: Relation between antibodies to chlamydia trachomatis and spontaneous abortion following IVF. Journal of Assisted Reproduction and Genetics. 9: 207, 1992.
  3. Licciardi F, Gonzalez A, Neev Y, Tadir Y, Tang Y, Grifo J, Cohen J: A contact-free microscope delivered laser ablation system for opening of the mouse zona pellucida prior to blastomere biopsy. Journal of Assisted Reproduction and Genetics. 12:462-466, 1995.
  4. Alikani M, Cohen J, Licciardi F, Talansky BE: Micromanipulation. In: Progress in Reproductive Endocrinology. R. Asch and J. Studd (eds).  Parthenon Publishing, London, 1992.
  5. Li L, Munne S, Licciardi F, Neev J, Tadir Y, Berns M, Godice R, Cohen J. Microinjection of FITC-dextran into mouse blastomeres to assess topical effects of zona photoablation. Zygote 1: 43-48, 1993.
  6. Neen J, Gonzalez A, Licciardi F, Alikani M, Takir Y, Berns M, Cohen J. Opening of the mouse zona pellucida by laser without a micromanipulator.  Human Reproduction, 1993.
  7. Comerci JT, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature Cystic Teratoma: A clinic-pathologic evaluation of 517 cases and review of the literature. Obstetrics and Gynecology. 84:22-28, 1994
  8. Licciardi F, Schwartz LB, Schmidt-Sarosi C. A tenaculum improves ovarian accessibility during difficult transvaginal follicular aspiration: A novel but simple technique. Fertility and Sterility: 63: 677-679, 1995
  9. Schmidt-Sarosi C, Kaplan D, Sarosi P, Essig M, Licciardi F, Ketz M, Levitz M. Ovulation triggering in Clomiphene citrate stimulated cycles: HCG vs. a GNRH agonist. Journal of Assisted Reproduction and Genetics, 12: 167-175, 1995
  10. Buyon J, Kalunian K, Skovron M, Petri M, Lahita R, Merril J, Sammaritano L, Yung C, Licciardi F, Belmont M, Hahn B. Can women with systemic lupus erythematosus safely use exogenous estrogens? Journal of Clinical Rheumatology. 40: 98-108, 1995.
  11. Licciardi F, Vitenson B, Moldinando T, Schmidt-Sarosi C. Oocyte Donation and pregnancy in menopausal women. Contemporary OB/GYN. 40: 98-108, 1995.
  12. Licciardi F, Lui H-C, Rosenwaks Z. Day 3 estradiol serum concentrations as prognostrators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertility and Sterility.  64: 991-994, 1995.
  13. Giatras K, Licciardi F, Grifo JA. Laparoscopic Resection of a non-communication rudimentary uterine horn. Journal of the American Association of Gynecologic Laparoscopists. 4:491-493, 1997.
  14. Wallerstein R, Jansen V, Grifo J, Berkeley A, Noyes N, Licker J, Licciardi F. Genetic screening of prospective oocyte donors.  Fertility and Sterility. 70: 52-54, 1998.
  15. Giatras K, Licciardi F, Grifo JA. Laparoscopy for pelvic pain in the Mayer-Rokitansky-Kuster-Hauser Syndrome: A case report. Journal of Reproductive Medicine. 43: 203-205, 1998.
  16. Giatras K, Berkeley AS, Noyes N, Licciardi F, Lolis D, Grifo JA. Fertility after hysteroscopic resection of submucous myomas. Journal of the American Association of Gynecologic Laparoscopists. Accepted for publication.
  17. Licciardi F, Kwiatkowski A, Noyes N, Berkeley AS, Grifo JA.  Oral vs. IM Progesterone for in vitro fertilization: A prospective randomized study. Fertility and Sterility. Fertility and Sterility 71:614-618, 1999
  18. Angelopoulos T, Adler A, Krey L, Licciardi F, Noyes N, McCullough A. Enhancement or initiation of testicular sperm motility by in vitro culture of testicular tissue. Fertility and Sterility 71: 240-244, 1999
  19. Noyes N, Licciardi F, Grifo JA, Krey L, Berkeley A. In vitro fertilization outcome relative to embryo transfer difficulty: A novel approach to the forbidding cervix. Fertility and sterility. 72:261-5, 1999.
  20. Licciardi F, Berkeley AS, Noyes N, Krey L, Grifo JA. A two vs. three-embryo transfer: The oocyte donation model. Fertility and Sterility 75:510-3, 2001
  21. Noyes N, Hampton BS, Berkeley A, Licciardi F, Grifo J, Krey L. Factors Useful in Predicting the Success of Oocyte Donation: a 3-year Retrospective Analysis: Fertility and Sterility 76: 2001.
  22. Chalian R, Licciardi F, Rebarber A, Del Priore G.
    Successful Infertility Treatment in a Cancer Patient with a Significant Personal and Family History of Cancer. Journal of Women’s Health;13: 2004, 1-3.

Abstracts:

  1. Licciardi F, Gregori C, Breen J. Mature teratomas: An analysis of 573 cases. Presented at the American College of Obstetricians and Gynecologists, Districts 3, Washington DC, 1990.
  2. Licciardi F, Liu H-C, Berkeley A, Cholst I, Davis O, Graf M, Noyes N, Rosenwaks Z. Day 3 estradiol levels as prognosticators of pregnancy outcome in In Vitro Fertilization, both alone and in conjunction with day FSH levels. Presented at the Society of Gynecologic investigation.  San Antonio, Texas, March 1991.
  3. Licciardi F, Liu H-C, Davis O, Graf M, Grifo J, Rosenwaks Z: Day 3 estradiol levels improve the significance of day 3 FSH levels in predicting follicle number, fertilization rate, number of oocytes transferred and pregnancy outcome. Presented at the 7th World Congress on In Vitro Fertilization and Assisted Procreation, Paris, 1991.
  4. Licciardi F, Liu HC, Davis O, Graf M, Grifo J, Rosenwaks Z: Relationship between antibodies to chlamydia trachomatis and abortion after IVF. Presented at the 7th World Congress on In Vitro Fertilization and Assisted Procreation, Paris 1991.
  5. Licciardi F, Liu H-C, Berkeley A, Cholst I, Davis O, Graf M, Grifo J, Noyes N, Rosenwaks Z. Random day 3 FSH and estradiol levels are predictive of IVF outcome in patients undergoing controlled ovarian hyperstimulation with luteal leuprolide acetate suppression. Presented at the Society of Gynecologic Investigation, San Antonio Texas, March 1992.
  6. Licciardi F, Rosenwaks Z, Schattman G, Cohen J, Witkin S, Detection of chlamydia trachomatis by the polymerase chain reaction in semen of asymptomatic men: relation to pregnancy outcome following IVF. Presented at the American Fertility Society, New Orleans, October 1992.
  7. Noyes N, Berkeley A, Davis O, Graf M, Grifo J, Licciardi F, Schattman G, Rosenwaks Z. Endometrial thickness/configuration does not appear to be a significant factor in embryo implantation. Presented at the American Fertility Society, New Orleans, October, 1992.
  8. Schmidt-Sarosi C, Kaplan D, Sarosi P, Essig M, Keltz M, Licciardi F, Levitz M, Ovulation triggering in Clomiphene stimulated cycles:  HCG US a Gonadotropin releasing hormone agonist. American Fertility Society, Montreal Canada, 1993.
  9. Noyes N, Krey L, Grifo J, Licciardi F, Berkeley A, Embryo quality predicts multi fetal pregnancy following IVF. American Society of Reproductive Medicine. October, 1996. Abstract #039
  10. Licciardi F, Berkeley A, Noyes N, Schmidt-Sarosi C, Fantini D, Grifo J. Leuprolide Acetate Depot for Oocyte Donation vs. Leuprolide Acetate SQ for young IVF patients: A comparative study. American Society for Reproductive Medicine, October, 1996. Abstract #164.
  11. Licciardi F, Jansen V, Fantini D, McGoff N, Berkeley AS. Strict genetic screening is necessary for Oocyte Donors. World Congress of IVF, Vancouver Canada, 1997.
  12. Noyes N, Moshel Y, Santiago C, Levitz M, Grifo JA, Licciardi F, Berkeley A, Krey LC. Serum androgen profiles associated with different follicle stimulation protocols for IVF. World Congress of IVF, Vancouver Canada, 1997.
  13. Roe A, Levitz M, Krey LC, Licciardi F, Berkeley AS. The presence of CMV IgG antibody does not affect pregnancy outcome in oocyte recipients World Congress of IVF, Vancouver Canada, 1997.
  14. Zhang J, Blaszczyk A, Grifo JA, Olizi J, Adler A, Berkeley AS, Licciardi F, Noyes N, Krey LC: Electrical activation and IVF development of human oocytes which failed fertilization following Intracytoplasmic sperm injection. American Society of Reproductive Medicine Annual Meeting, October 1997 Prize Poster.
  15. Zhang J, Blaszczyk AS, Grifo JA, Li L, Licciardi F, Noyes N, Krey LC. Reconstruction of human M11 oocytes by partial cytoplasmic substitution. American Society Of Reproductive Medicine Annual Meeting, October, 1997.
  16. Berkeley AS, Noyes N, Licciardi F, Grifo JA, Krey LC. The number of embryos transferred affects pregnancy and multiple gestation rates as influenced by age. World Congress on IVF, Australia, 1999.
  17. Noyes N, Hampton BS, Berkeley AS, Licciardi F, Grifo JA, Fantini D, Krey LC. What factors predict success in oocyte donation? World Congress on IVF, Australia, 1999.
  18. Noyes N, Hampton BS, Berkeley AS, Licciardi F, Grifo JA, Fantini D, Krey LC. Usefulness of endocrine and ultrasound follicular monitoring in oocyte donation cycles. World Congress on IVF, Australia, 1999.
  19. Noyes N, Grifo JA, Licciardi F, Berkeley AS, Krey LC. Recombinant FSH in ovulation and IVF. World Congress on IVF, Australia, 1999.
  20. Licciardi F, Berkeley AS, Noyes N, McGoff, Fantini D, Grifo JA. Method of leuprolide acetate administration influences ovarian response to exogenous Gonadotropin stimulation. American Society of Reproductive Medicine Annual Meeting, September 1999.
  21. Licciardi F, Berkeley AS, Noyes N, Krey L, Grifo JA. A two vs. three-embryo transfer: The oocyte donation model. Accepted for the American Society of Reproductive Medicine annual meeting, October 2000.
  22. Nasseri A, Mukerjeet T, Berkeley AS, Licciardi F, Krey L, Copperman A. Predictors of discordant outcome in paired ovum recipients.  American Society of Reproductive Medicine, October 2000.
  23. Licciardi F, Sanghui A, Lawson F, Krey L. Crinone vaginal gel vs. intra-muscular progesterone: Clinical and endocrinologic differences.  American Society of Reproductive Medicine, Orlando, 2001.
  24. Styne A, Krey L, Kwiatkowski A, Licciardi F, Noyes N. Pregnancy outcome and complications in women age 40 or older undergoing in vitro fertilization with autologous and donor oocytes. American Society of Reproductive Medicine, Seattle 2002.
  25. Kump L, Jansen V, Baek K, Lee S, Schiffman M, Licciardi F.  Extensive screening of oocyte donors is nonetheless a worthwhile process.  American Society of Reproductive Medicine, Seattle, 2002.
  26. Licciardi F, Kump L, Berkeley A, Noyes N, Grifo J, Krey L.  Sharing oocyte donors makes more sense scientifically, clinically and financially. American Society of Reproductive Medicine, Seattle, 2002.
  27. Kump L, Jansen V, Baek K, Styne A, Licciardi F. The importance of genetic screening for oocyte donors. American Society of Reproductive Medicine, Seattle, 2002.
  28. Montoya A, Licciardi F, Krey L. Estradiol: oocyte ratio, an early predictor of reduced ovarian reserve. American Society of Reproductive Medicine, Seattle, 2002.
  29. Kump L, Lee S, Schiffman M, Baek K, Styne A, Licciardi F.  Psychologic screening of prospective oocyte donors. American Society of Reproductive Medicine, Seattle, 2002.
  30. Nasseri A, Berkeley A, Licciardi F, Krey L, Terzano E, Grifo J. Comparison of ectopic pregnancy rates between patients undergoing embryo transfer on day 3 vs. day 5. American Society of Reproductive Medicine, Seattle, 2002. 
  31. Offspring Gender Ratios Differ between Day 3 and Day 5 Embryo Transfer. C. McCaffrey, A. Berkeley, J. Grifo, L. Kump, F. Licciardi, N. Noyes. American Society of Reproductive Medicine, San Antonio, 2003.

  32. The Prognosis for Patients with a Cancelled IVF Cycle. G. Fruhman, L. Krey, F. Licciardi. American Society of Reproductive Medicine, San Antonio, 2003.

  33. An Oocyte Donor’s Willingness to Donate- Does the Recipient’s Lifestyle Make a Difference? L. Kump, F. Licciardi, L. Krey, N. Noyes, J. Grifo, A. Berkeley. American Society of Reproductive Medicine, San Antonio, 2003.

 
 
©2008 DR. FRED LICCIARDI, SPECIALIST IN REPRODUCTIVE MEDICINE & SURGERY, 212-263-7754.